Novocure Ltd. (NVCR) Social Stream
NOVOCURE LTD (NVCR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NOVOCURE LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 7 | $200 | $85 | $151.5 | $57.07 | 165.46% |
| 2022-01-03 | 8 | $200 | $82 | $141.571 | $57.07 | 148.07% |
| 2022-01-06 | 8 | $200 | $82 | $134.428 | $57.07 | 135.55% |
| 2022-01-11 | 8 | $200 | $45 | $112.285 | $57.07 | 96.75% |
| 2022-01-20 | 8 | $200 | $45 | $112.285 | $57.07 | 96.75% |
| 2022-02-02 | 8 | $200 | $45 | $110.5 | $57.07 | 93.62% |
| 2022-02-08 | 9 | $200 | $45 | $120.444 | $57.07 | 111.05% |
| 2022-02-25 | 9 | $200 | $45 | $114.777 | $57.07 | 101.12% |
| 2022-05-08 | 9 | $200 | $45 | $114.333 | $57.07 | 100.34% |
| 2022-05-13 | 9 | $200 | $45 | $111.555 | $57.07 | 95.47% |
| 2022-06-06 | 10 | $200 | $45 | $111.9 | $57.07 | 96.07% |
| 2022-07-11 | 9 | $200 | $45 | $113.444 | $57.07 | 98.78% |
| 2022-07-29 | 9 | $200 | $45 | $110.111 | $57.07 | 92.94% |
| 2022-08-02 | 7 | $200 | $45 | $98.875 | $57.07 | 73.25% |
| 2022-10-24 | 7 | $200 | $45 | $96.375 | $57.07 | 68.87% |
| 2022-10-28 | 7 | $200 | $45 | $94.125 | $57.07 | 64.93% |
| 2022-11-29 | 8 | $200 | $43 | $96.25 | $57.07 | 68.65% |
| 2022-12-06 | 8 | $200 | $43 | $96.125 | $57.07 | 68.43% |
| 2022-12-22 | 8 | $200 | $43 | $96.5 | $57.07 | 69.09% |
| 2023-01-06 | 8 | $200 | $65 | $109.285 | $57.07 | 91.49% |
| 2023-01-12 | 8 | $200 | $65 | $111.142 | $57.07 | 94.75% |
| 2023-01-17 | 8 | $200 | $65 | $112.571 | $57.07 | 97.25% |
| 2023-02-23 | 7 | $130 | $65 | $97.166 | $57.07 | 70.26% |
The Trend in the Analyst Price Target
Over the past 16 months, NVCR's average price target has gone down $54.33.
NVCR reports an average of 34.08% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-29 | 9 | 200 | 45 | 114.333 | 76.58 | 49.3% |
| 2022-07-29 | 9 | 200 | 45 | 98.875 | 67.99 | 45.43% |
| 2022-07-29 | 9 | 200 | 45 | 110.111 | 67.99 | 61.95% |
| 2022-10-28 | 8 | 200 | 43 | 94.375 | 70.06 | 34.71% |
| 2023-01-17 | 7 | 135 | 65 | 98.000 | 92.26 | 6.22% |
NVCR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 2 | 0 | 3 | 2 | 2 | 7 |
The Trend in the Broker Recommendations
Over the past 123 days, NVCR's average broker recommendation rating worsened by 0.29.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, NOVOCURE LTD's variance in analysts' estimates is lower than -2643.87% of them.
- NVCR has a higher number of analysts covering the stock than 550.68% of stocks in the large market cap category.
- NOVOCURE LTD's upside potential (average analyst target price relative to current price) is greater than 2433.37% of stocks in the large market cap category.
- In terms of how NOVOCURE LTD fares relative to Healthcare stocks, note that its average analyst price target is higher than 2391.62% of that group.
In the Medical Equipment industry, PODD, DXCM, and RMD are the three stocks most similar to NOVOCURE LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding NVCR using the data that counts. Try POWR Ratings for free.